Risk of ischemic stroke varies by ethnicity in patients with atrial fibrillation: A Swedish national cohort study

European Journal of Internal Medicine

Volumn 36, Issue , 2016, Pages e13-e15

  Ji, Jianguang ^a   Sundquist, Jan ^a,b   Sundquist, Kristina ^a,b  

^a Lund University/Region Skåne ^*  (Sweden)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atrial fibrillation; Ethnic; Stroke; Warfarin

Indexed keywords

WARFARIN; ANTICOAGULANT AGENT;

ADULT; AFGHANISTAN; AGE; AGED; ALCOHOLISM; ANTICOAGULANT THERAPY; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CHILE; COHORT ANALYSIS; COMORBIDITY; CONFOUNDING VARIABLE; DIABETES MELLITUS; EASTERN EUROPE; EDUCATIONAL STATUS; ETHNIC DIFFERENCE; FEMALE; HUMAN; HYPERTENSION; INCIDENCE; INDIA; LETTER; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MIDDLE EAST; OBESITY; OUTCOME VARIABLE; PAKISTAN; PREVALENCE; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SCANDINAVIA; SEX; SOUTHEAST ASIA; SOUTHERN EUROPE; SWEDE (PEOPLE); SWEDEN; TURKEY (REPUBLIC); USSR; VERY ELDERLY; WESTERN EUROPE; ASIAN CONTINENTAL ANCESTRY GROUP; CAUCASIAN; COMPLICATION; EPIDEMIOLOGY; ETHNIC GROUP; ETHNOLOGY; PROPORTIONAL HAZARDS MODEL; RISK; STATISTICS AND NUMERICAL DATA; STROKE;

AGED; AGED, 80 AND OVER; ANTICOAGULANTS; ASIAN CONTINENTAL ANCESTRY GROUP; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; COHORT STUDIES; ETHNIC GROUPS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK; STROKE; SWEDEN; WARFARIN;

EID: 84994123735     PISSN: 09536205     EISSN: 18790828     Source Type: Journal    
DOI: 10.1016/j.ejim.2016.08.027     Document Type: Letter

References (9)

1. [1] Wolf, P.A., Abbott, R.D., Kannel, W.B., Atrial fibrillation as an independent risk factor for stroke: the Framingham study. Stroke 22 (1991), 983–988.
2. [2] Spinler, S.A., Shafir, V., New oral anticoagulants for atrial fibrillation. Circulation 126 (2012), 133–137.
3. [3] January, C.T., Wann, L.S., Alpert, J.S., Calkins, H., Cigarroa, J.E., Cleveland, J.C. Jr., et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the Heart Rhythm Society. Circulation 130 (2014), 2071–2104.
4. [4] Ansari, J.G., Garcha, G.S., Lakkis, N., Oral anticoagulation in atrial fibrillation. Cardiovasc Hematol Agents Med Chem 12 (2014), 34–41.
5. [5] Mathur, R., Pollara, E., Hull, S., Schofield, P., Ashworth, M., Robson, J., Ethnicity and stroke risk in patients with atrial fibrillation. Heart 99 (2013), 1087–1092.
6. [6] Ji, J., Sundquist, J., Sundquist, K., Lactose intolerance and risk of lung, breast and ovarian cancers: aetiological clues from a population-based study in Sweden. Br J Cancer 112:1 (2015), 149–152.
7. [7] Ji, J., Zoller, B., Sundquist, K., Sundquist, J., Increased risks of coronary heart disease and stroke among spousal caregivers of cancer patients. Circulation 125 (2012), 1742–1747.
8. [8] Shen, A.Y., Chen, W., Yao, J.F., Brar, S.S., Wang, X., Go, A.S., Effect of race/ethnicity on the efficacy of warfarin: potential implications for prevention of stroke in patients with atrial fibrillation. CNS Drugs 22 (2008), 815–825.
9. [9] Blann, A., Bareford, D., Ethnic background is a determinant of average warfarin dose required to maintain the INR between 3.0 and 4.5. J Thromb Haemost 2 (2004), 525–526.